author-photo

Luis-Emilio Garcia-Perez

Eli Lilly and Company

30

Papers

352

Citations

Citation Trend

Filter By

Papers (21) Sort By

Journal Conference Others

Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes.

2021 Quality of Life Research
Show All
- Source
- Cite
- Save
Citations (1)
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics

2021
Show All
- Source
- Cite
- Save
Citations (0)
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics.

2021 Diabetes Therapy
Show All
- Source
- Cite
- Save
Citations (0)
673-P: Effect of Once-Weekly Dulaglutide 3.0 and 4.5 mg in Patients with Different Baseline Renal Function: Post-hoc Analysis from the Award-11 Trial

2021 Diabetes
Show All
- Source
- Cite
- Save
Citations (0)
PDB3 The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide & Liraglutide in Type 2 Diabetes Patients (TROPHIES): 6-Month Analysis Results

2020 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial.

2020 Lancet Neurology
Show All
- Source
- Cite
- Save
Citations (38)
Crossover Clinical Trial Assessing Patient PREFERence between the Dulaglutide Pen and the Semaglutide Pen (PREFER)

2019 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (16)
PDB82 THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE AND LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): COUNTRY-SPECIFIC BASELINE CHARACTERISTICS

2019 Value in Health
Show All
- Source
- Cite
- Save
Citations (2)
Generalizability of Glucagon‐Like Peptide‐1 Receptor Agonist Cardiovascular Outcome Trials to the Overall Type 2 Diabetes Population in the United States

2019 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (23)
Treatment effects of once-weekly dulaglutide versus insulin glargine in patients with different baseline glycemic patterns (based on high/low fasting or high/low postprandial glucose): A post hoc analysis of the AWARD-2 clinical trial

2019
Show All
- Source
- Cite
- Save
Citations (0)